Cargando…
Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes
Objective. To compare the serum concentration of IL-6, IL-10, TNF, IL-8, resistin, and adiponectin in type 1 diabetic patients with and without metabolic syndrome and to determine the cut-off point of the estimated glucose disposal rate that accurately differentiated these groups. Design. We conduct...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530274/ https://www.ncbi.nlm.nih.gov/pubmed/26273680 http://dx.doi.org/10.1155/2015/972073 |
_version_ | 1782384889361858560 |
---|---|
author | Ferreira-Hermosillo, Aldo Molina-Ayala, Mario Ramírez-Rentería, Claudia Vargas, Guadalupe Gonzalez, Baldomero Isibasi, Armando Archundia-Riveros, Irma Mendoza, Victoria |
author_facet | Ferreira-Hermosillo, Aldo Molina-Ayala, Mario Ramírez-Rentería, Claudia Vargas, Guadalupe Gonzalez, Baldomero Isibasi, Armando Archundia-Riveros, Irma Mendoza, Victoria |
author_sort | Ferreira-Hermosillo, Aldo |
collection | PubMed |
description | Objective. To compare the serum concentration of IL-6, IL-10, TNF, IL-8, resistin, and adiponectin in type 1 diabetic patients with and without metabolic syndrome and to determine the cut-off point of the estimated glucose disposal rate that accurately differentiated these groups. Design. We conducted a cross-sectional evaluation of all patients in our type 1 diabetes clinic from January 2012 to January 2013. Patients were considered to have metabolic syndrome when they fulfilled the joint statement criteria and were evaluated for clinical, biochemical, and immunological features. Methods. We determined serum IL-6, IL-8, IL-10, and TNF with flow cytometry and adiponectin and resistin concentrations with enzyme linked immunosorbent assay in patients with and without metabolic syndrome. We also compared estimated glucose disposal rate between groups. Results. We tested 140 patients. Forty-four percent fulfilled the metabolic syndrome criteria (n = 61), 54% had central obesity, 30% had hypertriglyceridemia, 29% had hypoalphalipoproteinemia, and 19% had hypertension. We observed that resistin concentrations were higher in patients with MS. Conclusion. We found a high prevalence of MS in Mexican patients with T1D. The increased level of resistin may be related to the increased fat mass and could be involved in the development of insulin resistance. |
format | Online Article Text |
id | pubmed-4530274 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-45302742015-08-13 Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes Ferreira-Hermosillo, Aldo Molina-Ayala, Mario Ramírez-Rentería, Claudia Vargas, Guadalupe Gonzalez, Baldomero Isibasi, Armando Archundia-Riveros, Irma Mendoza, Victoria J Diabetes Res Research Article Objective. To compare the serum concentration of IL-6, IL-10, TNF, IL-8, resistin, and adiponectin in type 1 diabetic patients with and without metabolic syndrome and to determine the cut-off point of the estimated glucose disposal rate that accurately differentiated these groups. Design. We conducted a cross-sectional evaluation of all patients in our type 1 diabetes clinic from January 2012 to January 2013. Patients were considered to have metabolic syndrome when they fulfilled the joint statement criteria and were evaluated for clinical, biochemical, and immunological features. Methods. We determined serum IL-6, IL-8, IL-10, and TNF with flow cytometry and adiponectin and resistin concentrations with enzyme linked immunosorbent assay in patients with and without metabolic syndrome. We also compared estimated glucose disposal rate between groups. Results. We tested 140 patients. Forty-four percent fulfilled the metabolic syndrome criteria (n = 61), 54% had central obesity, 30% had hypertriglyceridemia, 29% had hypoalphalipoproteinemia, and 19% had hypertension. We observed that resistin concentrations were higher in patients with MS. Conclusion. We found a high prevalence of MS in Mexican patients with T1D. The increased level of resistin may be related to the increased fat mass and could be involved in the development of insulin resistance. Hindawi Publishing Corporation 2015 2015-07-27 /pmc/articles/PMC4530274/ /pubmed/26273680 http://dx.doi.org/10.1155/2015/972073 Text en Copyright © 2015 Aldo Ferreira-Hermosillo et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Ferreira-Hermosillo, Aldo Molina-Ayala, Mario Ramírez-Rentería, Claudia Vargas, Guadalupe Gonzalez, Baldomero Isibasi, Armando Archundia-Riveros, Irma Mendoza, Victoria Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes |
title | Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes |
title_full | Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes |
title_fullStr | Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes |
title_full_unstemmed | Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes |
title_short | Inflammatory Cytokine Profile Associated with Metabolic Syndrome in Adult Patients with Type 1 Diabetes |
title_sort | inflammatory cytokine profile associated with metabolic syndrome in adult patients with type 1 diabetes |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530274/ https://www.ncbi.nlm.nih.gov/pubmed/26273680 http://dx.doi.org/10.1155/2015/972073 |
work_keys_str_mv | AT ferreirahermosilloaldo inflammatorycytokineprofileassociatedwithmetabolicsyndromeinadultpatientswithtype1diabetes AT molinaayalamario inflammatorycytokineprofileassociatedwithmetabolicsyndromeinadultpatientswithtype1diabetes AT ramirezrenteriaclaudia inflammatorycytokineprofileassociatedwithmetabolicsyndromeinadultpatientswithtype1diabetes AT vargasguadalupe inflammatorycytokineprofileassociatedwithmetabolicsyndromeinadultpatientswithtype1diabetes AT gonzalezbaldomero inflammatorycytokineprofileassociatedwithmetabolicsyndromeinadultpatientswithtype1diabetes AT isibasiarmando inflammatorycytokineprofileassociatedwithmetabolicsyndromeinadultpatientswithtype1diabetes AT archundiariverosirma inflammatorycytokineprofileassociatedwithmetabolicsyndromeinadultpatientswithtype1diabetes AT mendozavictoria inflammatorycytokineprofileassociatedwithmetabolicsyndromeinadultpatientswithtype1diabetes |